Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Genentech and Roche disclose new ROR-gamma modulators

Jan. 29, 2014

Canadian group discloses novel BTK inhibitors

Jan. 27, 2014

Gilead Sciences divulges novel JAK inhibitors

Jan. 22, 2014

Hanmi Pharmaceutical designs new CSF-1R inhibitors

Jan. 22, 2014

Novel EP4 receptor antagonists presented by Eli Lilly

Jan. 22, 2014

Pluristem's phase I/II trial of PLX-PAD cells in muscle injury meets primary endpoints

Jan. 21, 2014

Merck & Co. researchers report discovery of SYK inhibitors

Jan. 17, 2014

First patient dosed in phase II trial of BMN-111 in children with achondroplasia

Jan. 15, 2014

Discovery and characterization of an orally potent anti-inflammatory kinase inhibitor

Jan. 15, 2014

Fibrocell Science and Intrexon expand collaboration

Jan. 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....